Related Experiment Videos
[Efficacy and tolerance of dipivephrin].
Ophtalmologie : Organe De La Societe Francaise D'Ophtalmologie
|June 1, 1989
Summary
Dipivephrin effectively lowered intraocular pressure by 29.4% in glaucoma patients over six months. Most patients tolerated the treatment well, with only a few experiencing side effects.
Area of Science:
- Ophthalmology
- Pharmacology
Context:
- Glaucoma and ocular hypertension are leading causes of irreversible blindness.
- Effective management of intraocular pressure (IOP) is crucial for preventing optic nerve damage.
Purpose:
- To evaluate the efficacy and tolerance of dipivephrin in managing elevated intraocular pressure.
- To assess the long-term effects of dipivephrin over a six-month period.
Summary:
- A six-month study involved 30 patients with glaucoma or ocular hypertension.
- Dipivephrin treatment resulted in a significant mean IOP reduction of 29.4%.
- The drug was well-tolerated by 27 out of 30 patients; three were excluded due to adverse effects.
Impact:
- Dipivephrin demonstrates significant IOP-lowering potential in glaucoma patients.
- The drug exhibits a favorable safety profile for long-term use.
- Findings support dipivephrin as a viable therapeutic option for ocular hypertension management.